Leerink Partners Remains Sidelined on OvaScience (OVAS) Following 1Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
OvaScience (OVAS) Misses Q1 EPS by 8c
May 5, 2016 4:01 PM EDTOvaScience (NASDAQ: OVAS) reported Q1 EPS of ($0.80), $0.08 worse than the analyst estimate of ($0.72). Revenue for the quarter came in at $146 thousand versus the consensus estimate of $110 thousand.
"OvaScience is currently focused on building our operational platform to support the expansion of the AUGMENT... More
